Posts Tagged ‘XCO’

Pandora Call Options Pop As Shares Improve


Today’s tickers: P, CBS & XCO

P - Pandora Media, Inc. – Traders that appear to be speculating on a rebound in shares of the provider of Internet radio services turned-up the volume in Pandora Media call options today. Shares in Pandora, which have been beaten down in recent months, increased as much as 10.5% to $8.91 in the first half of the session before losing some steam to stand up 4.9% on the day at $8.45 as of 1:15 p.m. ET. The stock is down 15.0% year-to-date and more than 65.0% since touching a peak value of $26.00 at the June 2011 IPO. June expiry call options saw the most action today, with the $9.0 strike call changing hands more than 6,700 times versus open interest of just 354 contracts. Most of the $9.0 calls appear to have been purchased for an average premium of $0.76 apiece. Call buyers profit at expiration as long as shares in Pandora jump 15.0% to surpass the average breakeven point at $9.76 by June expiration. Traders positioning for shares to extend gains also snapped up around 1,000 in-the-money calls at the June $8.0 strike for a premium of $1.10 a-pop. Pandora Media, Inc. is slated to release first-quarter earnings after the market closes on May 24th.

CBS - CBS Corp. – A burst of call buying on CBS Corp. caught our eye today, with shares in the name trading up 1.2% at $33.31 in early-afternoon trade. The bulk of the options volume in the mass media company appears to be betting on continued near-term appreciation in the price of the underlying shares, perhaps ahead of the Company's first quarter earnings release after the final bell on May 1st. The most active contracts in play on CBS Corp. today are the May…
continue reading


Tags: , ,




Contrarian Player Positions for Rebound in Cytokinetics Shares in 2011

 Today’s tickers: CYTK, SNDK, XCO, GIII & CFN

CYTK - Cytokinetics, Inc. – One bullish options investor appears to be taking advantage of the massive pullback in the price of the biopharmaceutical company’s shares today by initiating a sizeable buy-write strategy using call options expiring in June of 2011. Cytokinetics’ shares fell as much as 23.2% during the session to touch an intraday low of $2.25 despite seemingly positive results from its Phase 2a trial of its experimental drug therapy aimed at improving quality of life for patients suffering from Lou Gehrig’s disease. Reports indicated the firm plans to launch another mid-stage trial to test multiple doses of the drug over a three-month period in the first half of 2011. The covered-call seller populating CYTK today is well positioned to benefit from a rebound in the price of the underlying shares in the first half of 2011. It looks like the investor purchased 395,000 shares of CYTK at a price of $2.32 each, and sold 3,950 calls at the June 2011 $2.5 strike for a premium of $0.45 a-pop. The sale of the call options effectively reduces the price paid to get long the stock from $2.32 a share to $1.87 each. Thus, the buy-write strategist is positioned to accrue maximum gains of 33.7% on the long stock position in the event that Cytokinetics’ shares surge 11.1% over today’s low of $2.25 to exceed $2.50 a share ahead of expiration day in June. The investor may have the underlying stock position called from him at $2.50 each if the calls land in-the-money at expiration, thus allowing him to exit the position with the 33.7% rise in shares from $1.87 to $2.50. More than 4,050 calls changed hands at the June 2011 $2.5 strike today, versus previously existing open interest of just 451 contracts at that strike.

SNDK - SanDisk Corp. – Bulls are picking up in- and out-of-the-money call options on the maker of flash-based storage products once again today with shares in SanDisk Corp. trading…
continue reading


Tags: , , , ,




Bearish Player Initiates Ratio Put Spread at Staples

Today’s tickers: SPLS, XCO, THC, FTO, YHOO, ERTS, LNC & GE

SPLS - Staples, Inc. – The supplier of office products popped up on our ‘hot by options volume’ market scanner late in the trading session after one investor initiated a bearish spread in the December contract. Staples’ shares are currently down 0.80% at $20.64 as of 3:15 p.m. in New York. The pessimistic player established a ratio put spread, buying 2,500 in-the-money puts at the December $21 strike for an average premium of $1.185 each, and selling 5,000 puts at the lower December $19 strike at an average premium of $0.39 apiece. The average net cost of the transaction amounts to $0.405 per contract. Thus, the investor is prepared to make money if the price of the underlying stock slips beneath the effective breakeven point on the spread at $20.595 by expiration day in December. Maximum potential profits of $1.595 per contract are available to the ratio-spreader if the office products company’s shares fall 7.945% from the current price of $20.64 to settle at $19.00 at expiration. The investor is vulnerable to losses in the event that Staples’ shares plummet far lower than he expects they will in the next several months. Losses start to accumulate for the trader if shares drop 15.7% lower and trade below the lower breakeven point at $17.405 by expiration day. Staples, Inc. is slated to report third-quarter earnings ahead of the opening bell on November 18, 2010.

XCO - EXCO Resources, Inc. – The oil and natural gas company was visited by one long-term bullish options investor in the second half of the trading session. It looks like the trader is expecting EXCO’s shares to rally significantly by expiration day in March of 2011. Shares of the Dallas, TX-based firm are up 2.05% at…
continue reading


Tags: , , , , , , ,




Strangle Strategist Targets VeriSign Options

Today’s tickers: VRSN, CAT, EWZ & XCO

VRSN – VeriSign, Inc. – Symantec Corp. agreed to shell out $1.28 billion in cash to purchase VeriSign Inc.’s authentication services unit in a deal reportedly set to close by the end of September. Despite securing a buyer for its unit, which certifies that websites are legitimate and safe for online transactions, VeriSign’s shares are lower by 1.75% to stand at $27.50 as of 11:20 am (ET). VeriSign received an upgrade to ‘buy’ from ‘hold’ at Deutsche Bank today where analysts tout a 12-month target share price of $35.00 on the stock. One options strategist expecting shares of the underlying stock to remain range-bound through September expiration sold a strangle to reap the benefits of inflated options implied volatility. The investor sold 10,300 calls at the September $31 strike for a premium of $1.00 each and sold the same number of puts at the lower September $28 strike for $2.85 apiece. Gross premium pocketed on the transaction amounts to $3.85 per contract. The trader keeps the full premium received on the sale as long as shares trade within the range of the strike prices described through expiration. The short sale of both call and put options expose the investor to potential losses should shares rally above the upper breakeven price of $34.85, or if shares slip beneath the lower breakeven point at $24.15, ahead of expiration. Another investor opted to take profits off the table by selling a previously established long call position in the September contract. Perhaps the trader is taking in whatever profits are available now in case shares continue lower ahead of expiration. It looks like the investor originally purchased at least 15,000 calls at the September $28 strike for an average premium of $1.45 apiece back on April 15, 2010, when shares were trading at a volume-weighted average premium of $26.84. Today the options trader sold 15,000 calls at that strike for a premium of $2.15 each, receiving net profits of $0.70 per contract. In hindsight the investor could have raked in more substantial gains had he sold the calls yesterday when VeriSign’s shares surged to a 52-week high of $29.23 on the news Symantec Corp. agreed to buy out the authentication services unit at VRSN.

CAT – Caterpillar, Inc. – Options activity on the machinery manufacturer casts a glimmer of optimism on the stock despite the 4.45% decline…
continue reading


Tags: , , ,




 
 
 

Phil's Favorites

How Netflix affects what we watch and who we are - and it's not just the algorithm

 

How Netflix affects what we watch and who we are – and it’s not just the algorithm

pixinoo / Shutterstock

Courtesy of David Beer, University of York

Netflix’s dystopian Korean drama Squid Game has become the streaming platform’s biggest-ever series launch, with 111 million viewers watching at least two minutes of an episode.

Out of the thousands of programmes available on Netflix globally, how did so ...



more from Ilene

Zero Hedge

Where Are We In The Market Cycle?

Courtesy of Jesse Felder, TheFelderReport.com

(The following blog post was adapted from a recent Market Comment featured on The Felder Report PREMIUM, as published at ZeroHedge)

Lately, I’ve started to notice many signs suggesting we are now well past the peak in risk appetites. To begin with, Citi’s panic/euphoria model, developed by Tobias Levkovich (and renamed in his honor after he sadly passed away last weekend), is a terrific visual representation of this phenomenon. In the early part of this year, it soared to ...



more from Tyler

Politics

Steve Bannon faces criminal charges over Jan. 6 panel snub, setting up a showdown over executive privilege

 

Steve Bannon faces criminal charges over Jan. 6 panel snub, setting up a showdown over executive privilege

Defiant or following Trump’s direction? John Lamparski/NurPhoto via Getty Images

Courtesy of Kirsten Carlson, Wayne State University

The House committee investigating the Jan. 6 attack on the U.S. Capitol is tasked with providing as full an account as possible of the attempted insurrection. But there is a problem: Not everyone is cooperating.

As of Oct. 14, 2021, Steve Bannon, a one-tim...



more from Politics

Biotech/COVID-19

Ivermectin is a Nobel Prize-winning wonder drug - but not for COVID-19

 

Ivermectin is a Nobel Prize-winning wonder drug – but not for COVID-19

While ivermectin was originally used to treat river blindness, it has also been repurposed to treat other human parasitic infections. ISSOUF SANOGO/AFP via Getty Images

Courtesy of Jeffrey R. Aeschlimann, University of Connecticut

Ivermectin is an over 30-year-old wonder drug that treats life- and sight-threatening parasitic infections. Its lasting influence on global health has been so profound...



more from Biotech/COVID-19

Digital Currencies

Is This the Way?

 

Is This the Way?

Courtesy of 

A listener asked something that’s on a lot of investors’ minds? Should I be taking way more risk?

I’m 34 y/o and a couple of years ago a friend of mine took enormous financial risk, betting his life savings on obscure crypto coins (Elrond and Fantom). The bet paid off and he has managed to turn $30k into $6 million. Can you please help me make sense of this? I have always considered myself to be financially responsible, saving a large percentage every month for retirement.

I’m concerned I’m being too responsible and need to incorporate more risk into my portfolio. My Roth IRA/403(b) is...



more from Bitcoin

Chart School

Gold getting ready to move

Courtesy of Read the Ticker

By Xmas 2021 the DEM's must set a foundation for their run in US Mid Terms late in 2022. The DEM's have a few narrative problems, but one they wish to avoid is a 'stock market crash'. They must produce enough juice for the economy to hold up into the mid term elections.

In short it is more debt, a  higher debt ceiling, and more debt for the FED to buy, a larger balance sheet for the FED. This means hard currency remains in a uptrend and higher prices will be soon upon us.





Click for popup. Clear your browser cache if image is not showing.




...



more from Chart School

Promotions

Phil's Interview on Options Trading with TD Bank

TD Bank's host Bryan Rogers interviewed Phil on June 10 as part of TD's Options Education Month. If you missed the program, be sure to watch the video below. It should be required viewing for anyone trading or thinking about trading using options. 

Watch here:

TD's webinar with Phil (link) or right here at PSW

Screenshots of TD's slides illustrating Phil's examples:

 

 

&n...



more from Promotions

Kimble Charting Solutions

Crude Oil Cleared For Blast Off On This Dual Breakout?

Courtesy of Chris Kimble

Is Crude Oil about to blast off and hit much higher prices? It might be worth being aware of what could be taking place this month in this important commodity!

Crude Oil has created lower highs over the past 13-years, since peaking back in 2008, along line (1).

It created a “Double Top at (2), then it proceeded to decline more than 60% in four months.

The countertrend rally in Crude Oil has it attempting to break above its 13-year falling resistance as well as its double top at (3).

A successful breakout at (3) would suggest Crude Oil is about to mo...



more from Kimble C.S.

ValueWalk

Managing Investments As A Charity Or Nonprofit

By Anna Peel. Originally published at ValueWalk.

Maintaining financial viability is a constant challenge for charities and nonprofit organizations.

Q4 2020 hedge fund letters, conferences and more

The past year has underscored that challenge. The pandemic has not just affected investment returns – it’s also had serious implications for charitable activities and the ability to fundraise. For some organizations, it’s even raised doubts about whether they can continue to operate.

Finding ways to generate long-term, sustainable returns for ...



more from ValueWalk

Mapping The Market

Suez Canal: Critical Waterway Comes to a Halt

 

Suez Canal: Critical Waterway Comes to a Halt

Courtesy of Marcus Lu, Visual Capitalist

The Suez Canal: A Critical Waterway Comes to a Halt

On March 23, 2021, a massive ship named Ever Given became lodged in the Suez Canal, completely blocking traffic in both directions. According to the Suez Canal Authority, the 1,312 foot long (400 m) container ship ran aground during a sandstorm that caused low visibility, impacting the ship’s navigation. The vessel is owned by Taiwanese shipping firm, Evergreen Marine.

With over 2...



more from M.T.M.

The Technical Traders

Adaptive Fibonacci Price Modeling System Suggests Market Peak May Be Near

Courtesy of Technical Traders

Our Adaptive Fibonacci Price Modeling system is suggesting a moderate price peak may be already setting up in the NASDAQ while the Dow Jones, S&P500, and Transportation Index continue to rally beyond the projected Fibonacci Price Expansion Levels.  This indicates that capital may be shifting away from the already lofty Technology sector and into Basic Materials, Financials, Energy, Consumer Staples, Utilities, as well as other sectors.

This type of a structural market shift indicates a move away from speculation and towards Blue Chip returns. It suggests traders and investors are expecting the US consumer to come back strong (or at least hold up the market at...



more from Tech. Traders

Lee's Free Thinking

Texas, Florida, Arizona, Georgia - The Branch COVIDIANS Are Still Burning Down the House

 

Texas, Florida, Arizona, Georgia – The Branch COVIDIANS Are Still Burning Down the House

Courtesy of Lee Adler, WallStreetExaminer 

The numbers of new cases in some of the hardest hit COVID19 states have started to plateau, or even decline, over the past few days. A few pundits have noted it and concluded that it was a hopeful sign. 

Is it real or is something else going on? Like a restriction in the numbers of tests, or simply the inability to test enough, or are some people simply giving up on getting tested? Because as we all know from our dear leader, the less testing, the less...



more from Lee

Insider Scoop

Economic Data Scheduled For Friday

Courtesy of Benzinga

  • Data on nonfarm payrolls and unemployment rate for March will be released at 8:30 a.m. ET.
  • US Services Purchasing Managers' Index for March is scheduled for release at 9:45 a.m. ET.
  • The ISM's non-manufacturing index for March will be released at 10:00 a.m. ET.
  • The Baker Hughes North American rig count report for the latest week is scheduled for release at 1:00 p.m. ET.
...

http://www.insidercow.com/ more from Insider





About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. Contact Ilene to learn about our affiliate and content sharing programs.